Associate Director, Forecast And Performance

About KalVista Pharmaceuticals

KalVista Pharmaceuticals, Inc. (http://www.kalvista.com) is focused on the discovery, development, and commercialization of novel, oral therapies for diseases with significant unmet need, with an initial focus on hereditary angioedema (HAE). Listed on the Nasdaq Global Market, our headquarters is located in Cambridge, MA with additional offices and laboratories in Salisbury, UK; Zug, Switzerland; and Salt Lake City, UT.

The company has an R&D team with an established track record in the pharmaceutical development of small molecule protease inhibitors, world-leading expertise in the role of plasma kallikrein in disease, and a management team with the capability to bring small molecules through the clinic to commercialization.

KalVista now seeks an Associate Director, Forecast and Performance Reporting which is critical to the organization's mission as it prepares to commercialize sebetralstat, a novel, oral plasma kallikrein inhibitor. KalVista recently reported positive results from the KONFIDENT phase 3 study which demonstrated that sebetralstat met all efficacy endpoints for the treatment of HAE attacks and the safety profile was comparable to placebo. We plan to submit an NDA in the first half of 2024 with launch in 2025.

As the successful candidate for this position, you will fill a critical operating role within KalVista and be part of the Insight and Analytics Team. You will be a key member of the Insight and Analytics Leadership Team, responsible for developing and implementing forecasting models, delivering performance reporting, and providing insights to the US commercial team. This includes collaboration with the US commercial team to understand business needs, gather necessary information and inputs for reporting, and ensure the accuracy of forecast.

Responsibilities

• Lead the forecasting process and implement best-in class forecast modelling approaches and tools (e.g., standardization of input and output, brand dashboards, etc.)

• Support the annual and quarterly forecasting processes and monitor business performance against KPIs on a recurring basis

• Conduct root-cause analyses of historical performance versus forecast, generating new insights and informing future planning

• Ensure continuous development of forecasting process to create an agile and dynamic modelling process that can improve scope and accuracy

• Support new asset assessment, life-cycle management assessment, and business development activities

• Provide contextual forecasting support to business verticals (e.g., Finance, Supply Chain, Market research, Market Access) to ensure thorough understanding, and enable them to plan for future strategies and tactical investments

• Integrate forecasting insights with primary research, competitive intelligence, and analytics insights co-developed with peers across the Insights and Analytics team

• Oversee and manage weekly/monthly performance reporting and analytics

• Establish launch KPIs to inform organizational decision-making

• Cultivate strong relationships with key stakeholders across Market Research, Market Access, Finance, and Data Management. Share insights on areas of strength, opportunities, and recommendations for near-term growth

Requirements

• Bachelor's degree in business, science, or a related field

• Master's degree or MBA preferred

• 6-8 years of experience in forecasting or quantitative roles within Commercial/Insights and Analytics/Finance/Corporate strategy/BD in the biopharmaceutical industry

• Preferred experience in specialty/rare disease

• Deep expertise in advanced spreadsheets, patient-based forecast modelling (including dynamic patient models), data analysis, and data visualization tools

• Ability to explain complex concepts to stakeholders in simple language and lead/drive consensus building

• Demonstrated ability to think strategically to drive key business decisions

• Innovative mindset with the ability to take a creative approach to best meet the needs of both customers and KalVista